David L. Saussy

675 total citations
23 papers, 587 citations indexed

About

David L. Saussy is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, David L. Saussy has authored 23 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Physiology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in David L. Saussy's work include Receptor Mechanisms and Signaling (14 papers), Asthma and respiratory diseases (6 papers) and Neuroscience and Neuropharmacology Research (4 papers). David L. Saussy is often cited by papers focused on Receptor Mechanisms and Signaling (14 papers), Asthma and respiratory diseases (6 papers) and Neuroscience and Neuropharmacology Research (4 papers). David L. Saussy collaborates with scholars based in United States and United Kingdom. David L. Saussy's co-authors include Timothy A. True, Aaron S. Goetz, Thomas J. Rimele, Stuart D.C. Ward, Nobuko Hamaguchi, Peter W. Jeffs, Frank Navas, Eric C. Bigham, Michael J. Bishop and Jason D. Speake and has published in prestigious journals such as Biochemistry, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

David L. Saussy

23 papers receiving 563 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David L. Saussy United States 11 368 195 182 79 50 23 587
Timothy A. True United States 9 350 1.0× 190 1.0× 140 0.8× 46 0.6× 54 1.1× 12 475
Wesley L. Terasaki United States 9 684 1.9× 173 0.9× 201 1.1× 93 1.2× 37 0.7× 10 906
Iain G. Dougall United Kingdom 17 528 1.4× 229 1.2× 235 1.3× 98 1.2× 37 0.7× 29 939
Susumu Otomo Japan 14 356 1.0× 207 1.1× 88 0.5× 57 0.7× 40 0.8× 73 657
Jiann-Wu Wei Canada 16 619 1.7× 248 1.3× 126 0.7× 43 0.5× 21 0.4× 45 848
R.A. Podevin France 15 392 1.1× 166 0.9× 68 0.4× 28 0.4× 62 1.2× 23 608
Hans‐Peter Bär Canada 13 377 1.0× 109 0.6× 123 0.7× 45 0.6× 45 0.9× 24 636
Giuseppina Morini Italy 17 257 0.7× 143 0.7× 181 1.0× 184 2.3× 65 1.3× 74 799
Mary Keen United Kingdom 16 321 0.9× 179 0.9× 89 0.5× 21 0.3× 42 0.8× 38 503
Anna Rita Renzetti Italy 16 458 1.2× 422 2.2× 150 0.8× 83 1.1× 8 0.2× 45 739

Countries citing papers authored by David L. Saussy

Since Specialization
Citations

This map shows the geographic impact of David L. Saussy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Saussy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Saussy more than expected).

Fields of papers citing papers by David L. Saussy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Saussy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Saussy. The network helps show where David L. Saussy may publish in the future.

Co-authorship network of co-authors of David L. Saussy

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Saussy. A scholar is included among the top collaborators of David L. Saussy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Saussy. David L. Saussy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Speake, Jason D., Frank Navas, Michael J. Bishop, et al.. (2003). 2-(Anilinomethyl)imidazolines as α1 adrenergic receptor agonists: α1a subtype selective 2′-heteroaryl compounds. Bioorganic & Medicinal Chemistry Letters. 13(6). 1183–1186. 15 indexed citations
2.
Bishop, Michael J., Judd Berman, Eric C. Bigham, et al.. (2002). α1-Adrenoceptor Agonists: The Identification of Novel α1A Subtype Selective 2′-Heteroaryl-2-(phenoxymethyl)imidazolines. Bioorganic & Medicinal Chemistry Letters. 12(3). 471–475. 17 indexed citations
3.
Bigham, Eric C., James A. Liacos, Frank Navas, et al.. (2002). α1-Adrenoceptor activation: A comparison of 4-(Anilinomethyl)imidazoles and 4-(Phenoxymethyl)imidazoles to related 2-imidazolines. Bioorganic & Medicinal Chemistry Letters. 12(23). 3449–3452. 4 indexed citations
4.
Navas, Frank, Michael J. Bishop, Jason D. Speake, et al.. (2002). 2-(Anilinomethyl)imidazolines as α1A Adrenergic Receptor Agonists: 2′-Heteroaryl and 2′-Oxime Ether Series. Bioorganic & Medicinal Chemistry Letters. 12(4). 575–579. 9 indexed citations
5.
Bishop, Michael J., Judd Berman, Eric C. Bigham, et al.. (2001). 2-(Anilinomethyl)imidazolines as α1-adrenoceptor agonists: the identification of α1A subtype selective 2′-carboxylic acid esters and amides. Bioorganic & Medicinal Chemistry Letters. 11(21). 2871–2874. 5 indexed citations
6.
Jackson, William T., Larry L. Froelich, Robert J. Boyd, et al.. (1999). Pharmacologic Actions of the Second-Generation Leukotriene B4 Receptor Antagonist LY293111: In Vitro Studies. Journal of Pharmacology and Experimental Therapeutics. 288(1). 286–294. 49 indexed citations
7.
Saussy, David L., et al.. (1999). Development of scintillation-proximity assays for alpha adrenoceptors. Journal of Pharmacological and Toxicological Methods. 42(4). 237–244. 21 indexed citations
8.
Hamaguchi, Nobuko, Timothy A. True, David L. Saussy, & Peter W. Jeffs. (1996). Phenylalanine in the Second Membrane-Spanning Domain of α1A-Adrenergic Receptor Determines Subtype Selectivity of Dihydropyridine Antagonists. Biochemistry. 35(45). 14312–14317. 43 indexed citations
9.
Lutz, Michael W., et al.. (1996). Experimental design for high-throughput screening. Drug Discovery Today. 1(7). 277–286. 34 indexed citations
10.
Goetz, Aaron S., et al.. (1995). BMY 7378 is a selective antagonist of the D subtype of α1-adrenoceptors. European Journal of Pharmacology. 272(2-3). R5–R6. 285 indexed citations
11.
Margolin, Nara, Timothy A. True, David L. Saussy, & Dale E. Mais. (1994). Effect of Alkaline Phosphatase on Thromboxane Mimetic Induced Platelet Activation. Prostaglandins. 48(4). 235–246. 3 indexed citations
12.
Bowling, Nancy, Gregory P. Dubé, Kellie A. Brune, et al.. (1994). Characterization of Thromboxane A2/Prostaglandin H2 Binding Sites in Guinea Pig Cardiac Membrane Preparations. Journal of Molecular and Cellular Cardiology. 26(7). 915–923. 10 indexed citations
13.
Wikel, James H., Michael J. Sofia, David L. Saussy, & Kerry G. Bemis. (1994). QSAR Study of ortho-phenylphenol leukotriene B4 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 4(6). 795–800. 3 indexed citations
14.
Sawyer, J. Scott, Nicholas J. Bach, Stephen Baker, et al.. (1994). Structural analogues of LY292728, a highly potent xanthone dicarboxylic acid leukotriene B4 receptor antagonist: spatial positioning of the secondary acid group. Bioorganic & Medicinal Chemistry Letters. 4(17). 2077–2082. 4 indexed citations
15.
Sawyer, J. Scott, Michael J. Sofia, Paul E. Floreancig, et al.. (1993). Biphenylyl-substituted xanthones: highly potent leukotriene B4 receptor antagonists. Journal of Medicinal Chemistry. 36(24). 3982–3984. 8 indexed citations
16.
Sawyer, J. Scott, et al.. (1993). Synthesis and pharmacologic activity of hydroxyacetophenone-substituted benzophenone/xanthone leukotriene B4 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 3(10). 1981–1984. 1 indexed citations
17.
Silbaugh, Steven A., Peter W. Stengel, Sandra L. Cockerham, et al.. (1992). Pulmonary actions of LY255283, a leukotriene B4 receptor antagonist. European Journal of Pharmacology. 223(1). 57–64. 17 indexed citations
18.
Sofia, Michael J., David L. Saussy, William T. Jackson, et al.. (1992). -alkoxyphenol leukotriene B4 receptor antagonists: effect of a chroman carboxylic acid.. Bioorganic & Medicinal Chemistry Letters. 2(12). 1675–1680. 6 indexed citations
19.
Saussy, David L., Dale E. Mais, David Baron, Samuel H. Pepkowitz, & Perry V. Halushka. (1988). Subcellular localization of a thromboxane A2/prostaglandin H2 receptor antagonist binding site in human platelets. Biochemical Pharmacology. 37(4). 647–654. 6 indexed citations
20.
Halushka, Perry V., John MacDermot, Daniel R. Knapp, et al.. (1985). A novel approach for the study of thromboxane A2 and prostaglandin H2 receptors using an 125I-labeled ligand. Biochemical Pharmacology. 34(8). 1165–1170. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026